Blood Screening Market Size, Share and Forecast 2021-2027
The global blood screening market is anticipated to grow at a CAGR of 6.9% during the forecast period (2021-2027). The rising prevalence of COVID-19 cases, rising testing for the disease, increasing awareness for the treatment, and rising FDA approvals, are driving the blood screening market during the forecast period. According to the Worldometers, as of 10th May 2021, around 159 million COVID-19 cases were reported that have been tested positive. In March 2020, Becton, Dickson, and Co., a medical technology company, and BioMedomics, a North Carolina-based clinical diagnosis company, had launched the FDA-approved point-of-care test to detect antibodies in blood to confirm that the current or past exposure of COVID-19 in 15 minutes.
To Request a Sample of our Report on Blood Screening Market: https://www.omrglobal.com/request-sample/blood-screening-market
In July 2020, Becton, Dickinson, and Co. had announced that the US FDA
approved an Emergency Usage Authorization for a rapid, point-of-care SARS-CoV-2
diagnostic test for use with the BD VeritorTM Plus System, which is widely
available. The introduction of this new assay, which provides results in 15
minutes on a simple-to-use, highly portable instrument, is vital for increasing
access to COVID-19 diagnostics owing to it allows for real-time results and
decision-making while the patient is still in the hospital. Apart from it, in
February 2021, Siemens Healthcare GmbH had announced that the laboratory test
for the SARV-CoV-2 Antigen assay of the company got a CE mark and has submitted
the test to the US FDA for emergency use authorization (EUA). Thus, the various
technological advancements in the tests by key players, rising FDA approvals to
detect antibodies in the blood, new blood screening devices, and among others,
are the factors that are driving the growth of the market during the forecast
period.
Market
Coverage
·
The
market number available for – 2020-2027
·
Base
year- 2020
·
Forecast
period- 2021-2027
·
By
Screening Technology
·
By
Products
·
By
End-Users
·
North
America
·
Europe
·
Asia-Pacific
·
Rest of
the World
· Competitive Landscape- Abbott Laboratories, Becton Dickinson and Co., BioAim Scientific Inc, Bio-Rad Laboratories, Inc, Danaher Corporation, Demeditec Diagnostics GmbH, F. Hoffmann-La Roche Ltd., Grifols, Siemens Healthcare GmbH, Immuno-Biological Laboratories, Inc., among others.
Recent Activities by the Key Players in Global Blood Screening Market
·
In
April 2020, Abbott Laboratories had announced the launch of another COVID-19
test, which is a lab-based serology blood test for detection of antibody, IgG,
for defining the COVID-19 in the person’s body. This test tells that if a
person has been previously infected and how long antibodies stay in the
body.
·
In June
2019, Abbott Laboratories had got the US FDA approval for its Alinity line of laboratory
diagnostics hardware designed to blood screen and plasma donation for potential
containment. This was designed for a smaller space, also can perform 600 tests
in an hour.
A full
Report of Blood Screening Market is Available at: https://www.omrglobal.com/industry-reports/blood-screening-market
Global Blood
Screening Market Report Segment
·
Nucleic
Acid Amplification Test
·
Western
Blotting
·
Enzyme-Linked
Immunosorbent Assay
·
PCR-RNA
By Products
·
Testing
Instruments
·
Reagents
·
By
End-Users
·
Blood
Banks
·
Hospitals
·
Laboratories
Regional
Analysis
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of The World
- Latin America
- Middle East and Africa
Company
Profiles
·
Abbott
Laboratories
·
Becton,
Dickinson and Co.
·
BioAim
Scientific Inc.
·
bioMérieux,
Inc.
·
Bio-Rad
Laboratories, Inc.
·
BioVision
Inc.
·
Boster
Biological Technology
·
Cosmo
Bio Co., Ltd.
·
Cusabio
Technology LLC
·
Danaher
Corp.
·
Demeditec
Diagnostics GmbH
·
F.
Hoffmann-La Roche Ltd.
·
Grifols,
S.A.
·
Immuno-Biological
Laboratories, Inc.
·
Innovative
Research, Inc.
·
OriGene
Technologies Inc.
·
Ortho-Clinical
Diagnostics, Inc. (OCD)
·
RayBiotech,
Inc.
·
Siemens
Healthcare GmbH
·
Thermo
Fisher Scientific Inc.
Reasons for Buying from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/blood-screening-market
About Orion
Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment